FXC.L
iShares China Large Cap UCITS ETF
Emerging Market
EQUITY
Passive
MANAGEMENT STYLE
£ 727.3 M
ASSETS UNDER MGMT
74 bp
EXPENSES
Fund Basics
| Inception date | Oct 21, 2004 |
| Regulation | UCITS |
| ISIN | IE00B02KXK85 |
| Distributions | Quarterly |
| Currency | GBp |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ALIBABA GROUP HOLDING LTD. | 8.8 % |
| CHINA CONSTRUCTION BANK-H | 8.2 % |
| TENCENT HOLDINGS LTD | 7.7 % |
| IND & COMM BK OF CHINA - H | 5.9 % |
| XIAOMI CORP. CLASS B | 5.6 % |
| MEITUAN DIANPING | 4.8 % |
| PING AN INSURANCE GROUP CO-H | 4.4 % |
| BYD CO LTD-H | 4.0 % |
| BANK OF CHINA LTD - H | 3.7 % |
| NETEASE, INC | 3.5 % |
Constituent Breakdown
| Number of holdings | 60 |
| Herfindahl-Hirschman Index | 426 |
| Wgt avg mkt cap (mns) | $142,958 |
| Large cap (>$10bn) | 92.4% |
| Mid cap ($2-10bn) | 4.9% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 1.8% |
| Emerging mkts. | 96.8% |
Sector Breakdown
Country Exposure
 |
CHINA | 96.8 % |
 |
HONG KONG | 1.8 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -8.6% | 0.8% | 11.9% | 8.2% | -4.3% | 1.4% | 3.5% | 4.8% |
| Dividend Yield | 0.0% | 2.0% | 3.4% | 3.2% | 2.7% | 3.2% | 3.5% | 3.6% |
| Total Returns | -8.6% | 2.8% | 15.3% | 11.4% | -1.6% | 4.6% | 7.0% | 8.4% | Ann. Volatility | 17.4% | 17.6% | 24.0% | 24.9% | 28.1% | 24.9% | 28.4% | 27.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.48 | 10% |
| MSCI EAFE | 0.32 | 8% |
| MSCI Emg Mkts | 0.43 | 24% |
Liquidity Measures
| Avg. volume (000) | 7 |
| ADV traded (mns) | $55 |
| Turnover | 7.5% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $7,736.03 |
| Relative strength (RSI) | 41 |
| MACD/Signal | -77.86/-36.90 |
| Bollinger Bands (Upper/Lower) | $8,072.58/$7,436.12 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FXC.L |
Expenses vs. FXC.L |
ALTAR Score™ vs. FXC.L |
|---|---|---|---|---|
| FXAC.AS | iShares China Large Cap UCITS ETF | 98.6% | 0 bp | +0.0% |
| BRIC.L | iShares BIC 50 UCITS ETF | 60.9% | 0 bp | +4.0% |
| CNEG.L | Amundi MSCI China ESG Selection UCITS ETF DR (C) | 58.4% | -39 bp | +3.5% |
| ASIU.L | Amundi MSCI China ESG Selection Extra UCITS ETF Acc | 56.4% | -9 bp | +3.6% |
| ICHN.AS | iShares MSCI China UCITS ETF | 52.1% | -46 bp | -1.3% |
| ICHD.AS | iShares MSCI China UCITS ETF | 52.1% | -46 bp | -1.4% |
| XCS7.DE | Xtrackers MSCI China UCITS ETF 1D | 51.0% | -46 bp | -1.3% |
| XCS6.DE | Xtrackers MSCI China UCITS ETF 1C | 50.9% | -9 bp | -1.8% |
| ACUU.DE | Amundi MSCI AC Far East Ex Japan ESG Selection UCITS ETF DR | 27.3% | -49 bp | -10.7% |
| XZEM.DE | Xtrackers MSCI Emerging Markets ESG UCITS ETF 1C | 25.8% | -49 bp | -7.3% |
Risk and Returns: FXC.L vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (GBP)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
20.9%
ALTAR SCORE™
99th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 217 funds in the Emerging Equity category with an average
ALTAR Score™ of 7.3% and a standard deviation
of 2.2%. FXC.L's ALTAR Score™ is approximately 6.1 standard
deviations above the category average. This places FXC.L in the 99th percentile
among funds in the category.
Sell-Side Consensus
£10996.2
PRICE TARGET
+40.9%
UPSIDE